GSK PLC 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:46 pm Purchase |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
GSK PLC | 8,550,954 6.500% |
1,924,927 (+29.05%) |
Filing |